Clinical Trials Browser

Completed × OTHER × Sunitinib × Clear all

NCT00814021 2026-04-15

Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain

Phase 2 Completed

CNSGenitourinary

Brain Neoplasms, Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Metastasis

NCT02555748 2026-03-31

SUP-R

Phase 4 Completed

Carcinoma, Renal Cell

NCT04394975 2025-11-28

Study to Evaluate the Efficacy and Safety of Toripalimab in Combination With Axitinib Versus Sunitinib Monotherapy in Advanced Renal Cell Cancer

Phase 3 Completed

Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1

NCT00930033 2025-09-05

CARMENA

Phase 3 Completed

Carcinoma, Renal Cell

NCT01286896 2025-07-10

Use of Individual Pharmacokinetically (PK)-Guided Sunitinib Dosing: A Feasibility Study in Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Malignant Solid Tumour

NCT00437372 2025-05-02

Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients

Phase 1 Completed

GynecologicHead & NeckThoracic

Head and Neck Neoplasms, Neoplasms, Nervous System Neoplasms, Pelvic Neoplasms, Thoracic Neoplasms

NCT02230176 2025-04-20

OCCLURANDOM

Phase 2 Completed

Somatostatinoma

NCT01254864 2025-01-27

Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapies

Phase 2 Completed

190 enrolled 9 charts

Prostatic Neoplasms

NCT00843037 2024-10-17

SNIPP

Phase 2 Completed

25 enrolled 19 charts

Neoplasm Metastasis, Paraganglioma, Pheochromocytoma

NCT03109015 2024-10-08

ASSET

Phase 2 Completed

7 enrolled 18 charts

Carcinoma, Renal Cell

NCT03277924 2024-08-13

ImmunoSarc

Phase 1/2 Completed

Chondrosarcoma, Extraskeletal Myxoid, Bone Neoplasms, Chondrosarcoma, Hemangioendothelioma, Hemangiosarcoma, Leiomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial, Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Hemangioendothelioma, Epithelioid, Histiocytoma, Malignant Fibrous, Solitary Fibrous Tumors

NCT01517243 2023-09-21

Phase II Study of Alternating Sunitinib and Temsirolimus

Phase 2 Completed

37 enrolled 13 charts

Carcinoma, Renal Cell

NCT00656669 2023-05-23

Exploratory Study of Sunitinib Malate as a Component of Neoadjuvant Therapy for Breast Cancer

Phase NA Completed

23 enrolled 12 charts

Breast Neoplasms

NCT00270413 2022-11-22

SU11248 as Consolidation After Response to Taxanes in Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT00981890 2022-10-07

Stereotactic Radiosurgery With Sunitinib for Brain Metastases

Phase 1 Completed

Brain Neoplasms

NCT01061411 2022-08-05

Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery

Phase 1 Completed

Carcinoma, Renal Cell

NCT01371201 2022-08-04

FIRSTMAPPP

Phase 2 Completed

Paraganglioma

NCT02450123 2022-06-15

Single-arm Study to Evaluate the Safety and Efficacy of Sunitinib, in Subjects With RET Fusion Positive or FGFR2 Amplification, Refractory Solid Tumors

Phase NA Completed

Other solid neoplasm

Refractory Solid Tumors

NCT02691793 2022-06-15

Study to Evaluate the Safety and Efficacy of Sunitinib, in Subject With Refractory Solid Tumors

Phase 4 Completed

Other solid neoplasm

Refractory Solid Tumors

NCT03170180 2022-06-15

Exploratory Study of Drug Sensitivity Prediction Software (IRCR-DReSS) With Patient-derived Tumor Cells of Metastatic Gastric Cancer

Phase 2 Completed

Gastrointestinal

Stomach Neoplasms

NCT01164202 2022-03-18

SATURNE

Phase 2/3 Completed

78 enrolled 9 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00695292 2021-11-22

Irinotecan, Carboplatin, and Sunitinib in First Line Extensive-Stage Small Cell Lung Cancer

Phase 2 Completed

37 enrolled 10 charts

Small Cell Lung Carcinoma

NCT02164240 2021-06-14

SURE

Phase 1 Completed

14 enrolled 8 charts

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT02960906 2021-04-26

BIONIKK

Phase 2 Completed

Clear-cell metastatic renal cell carcinoma

NCT01636908 2021-04-15

ICK

Phase NA Completed

Neoplasms

NCT00541008 2021-02-21

Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer

Phase 2 Completed

Carcinoma, Renal Cell, Kidney Neoplasms

NCT04368546 2021-01-27

Sunitinib Treatment on Tissue Sodium Accumulation (TSS2)

Hypertension

NCT03066427 2020-11-13

INMUNOSUN

Phase 2 Completed

Carcinoma, Renal Cell

NCT00668811 2020-08-05

IIT Sutent

Phase 2 Completed

23 enrolled 7 charts

EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

NCT01005472 2020-08-03

Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma

Phase 1 Completed

Uveal Melanoma, Melanoma

NCT02402062 2020-07-27

A Study to Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pancreatic Tumours

Phase 2 Completed

17 enrolled 55 charts

EndocrineGastrointestinalNET

Pancreatic Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

NCT00543504 2020-06-30

Bevacizumab in Multiple Phase I Combinations

Phase 1 Completed

Advanced Cancer

NCT02779283 2020-05-26

Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia

Phase 1 Completed

LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02713763 2020-03-04

RESUNET

Phase 2 Completed

EndocrineGastrointestinal

Pancreatic Neuroendocrine Tumour Metastatic

NCT02060370 2020-02-27

Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC)

Phase 2 Completed

60 enrolled 13 charts

Carcinoma, Renal Cell, Kidney Neoplasms, Urogenital Neoplasms

NCT00783653 2020-02-25

Clinical Study of SU 11248 (Sutent) Combined With Standard Chemotherapy in Patients With FLT3 Mutated AML Over 60 Years

Phase 1/2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00581789 2019-11-19

Erlotinib and Sunitinib in NSCLC

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung

NCT01551459 2019-10-29

SUAVE

Phase 2 Completed

Uveal Melanoma, Melanoma, Neoplasm Metastasis

NCT03379012 2019-10-22

FARETES

Phase 2 Completed

Carcinoma, Renal Cell

NCT00794950 2019-09-23

Sutent

Phase 2 Completed

43 enrolled 10 charts

Urinary Bladder Neoplasms

NCT03519542 2019-09-18

SOGANG

Carcinoma, Renal Cell

NCT00513695 2019-08-07

Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer

Phase 2 Completed

68 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT01309633 2019-07-22

Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)

Phase 2 Completed

Nasopharyngeal Carcinoma, Neoplasm Metastasis

NCT02058901 2019-07-17

Study of High-dose, Intermittent Sunitinib in Patients With Solid Tumors.

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT01026337 2019-06-25

Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer

Carcinoma, Renal Cell

NCT00526656 2019-04-16

Sunitinib in Treating Patients With Locally Advanced Bladder Cancer

Phase 2 Completed

9 enrolled 5 charts

Urinary Bladder Neoplasms

NCT02142036 2019-03-13

MetAction

Phase 2 Completed

Neoplasm Metastasis

NCT00806663 2019-02-06

FOLFIRI and Sunitinib in Metastatic Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Colorectal Neoplasms

NCT01731158 2019-02-06

BERAT

Phase 2 Completed

Carcinoma, Renal Cell

NCT00453895 2019-01-31

SIRAC

Phase 2 Completed

39 enrolled 10 charts

Adrenocortical Carcinoma